Stock, pipeline and biotech catalyst intelligence
Reported statements
| USD | 2022 |
|---|---|
| Revenue | — |
| R&D expense | $28.5M |
| Operating income | −$42.1M |
| Net income | −$39.6M |
| Cash & equivalents | $25.5M |
| Total debt | $1.7M |
| Operating cash flow | −$43.6M |
| Free cash flow | −$43.7M |
Company profile
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Company profile supplied by Yahoo Finance. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 21, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.